ArkVax secures investment to develop vaccine technology
ArkVax, a spin out company from the London School of Hygiene & Tropical Medicine (LSHTM) has secured seed investment from Start Codon, a venture capital investor and venture builder based in Cambridge (UK). The investment will enable ArkVax to both grow its team and develop its vaccine platform technology to proof of concept, initially for use in animals.
Jon Cuccui Brendan Wren London School Of Hygiene Tropical Medicine Sciences Research Council London School Tropical Medicine
Source: lshtm.ac.uk